ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Capital expenditures

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2025-2,171-1.63%
Dec 31, 2024-2,207+0.23%
Dec 31, 2023-2,202+23.92%
Dec 31, 2022-1,777-5.73%
Dec 31, 2021-1,885-13.41%
Dec 31, 2020-2,177+32.91%
Dec 31, 2019-1,638+17.50%
Dec 31, 2018-1,394+22.82%
Dec 31, 2017-1,135+1.25%
Dec 31, 2016-1,121+0.99%
Dec 31, 2015-1,110-3.06%
Dec 31, 2013-1,145-23.23%
Dec 31, 2011-1,491+46.93%
Dec 31, 2010-1,015

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat